OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as â€œcancer stem cellsâ€. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.
Current Team (12)Update
Senior Vice President and Chief Financial Officer
Senior Vice President, Chief Medical Officer
Senior Vice President, Molecular and Cellular Biology
Vice President, Regulatory Affairs
Senior Vice President, Cancer Biology
Vice President, General Counsel
President and CEO
Vice President, Translational Medicine
Funding Rounds (3) - $196.2MUpdate
Board Members and Advisors (6)Update
Early stage healthcare
U.S. Venture Partners (USVP) is a leading Silicon valley-based venture capital firm, helping...
Morgenthaler Ventures is a venture capital and private equity firm that invests in IT and life...
med device, biotech vc
DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device...
Adams Street Partners is a private equity investor that has been investing since 1972. They...
LIfe Sciences Venture Firm
Bay Partners is a venture capital firm based in Menlo Park, California. Founded by John...
800 Chesapeake Drive
Redwood City, CA 94063
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds...
- 07/18/13 -nasdaq.com